Law360, New York (October 19, 2009) -- Lundbeck A/S and Forest Laboratories Inc. will have to pay Infosint SA a $15 million reasonable royalty award now that a federal jury has ruled that Infosint's patent for making the antidepressant citalopram is valid.
A jury in the U.S. District Court for the Southern District of New York on Thursday found that a process used by Lundbeck for making racemic citalopram and escitalopram, the...
